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Mumps as a disease of military personnel may be exceedingly troublesome, 
causing loss of much time from duty and interfering seriously with the move- 
ment  of troops  (1,  2).  This fact induced us  to undertake the  experiments 
which are described in this and the following papers with the hope that ways 
may be found by which epidemics can be controlled? 
The  fundamental  researches  of  Johnson  and  Goodpasture  (4-7)  demon- 
strated  the  causative  agent  of mumps  to be a  filterable virus  and revealed 
certain important facts concerning passive and  active  immunization  of  the 
monkey  against  experimental  inoculation.  Their  investigations,  however, 
left unsolved a number of practical problems.  Among the more important are: 
(a) the development of specific methods of diagnosis, particularly in doubtful 
cases in which parotitis is absent or is not a prominent feature; (b) the deter- 
mination of a convenient method for the revelation of susceptibility or resist- 
ance among human beings--especially among those who have never experienced 
an apparent illness but of whom some may have had the disease in an inap- 
parent or "silent" form; (c) the discovery of a means of effectively conferring 
active immunity upon susceptible individuals; (d) the development of methods 
for the assay of the protective properties of convalescent sera for the value of 
which some clinical evidence has been presented (8, 9). 
In the present paper experiments on monkeys (M. mulatta)  are described  2 
which gave results  that  seem significant for the solution of certain of these 
* These investigations have been carried out in part as projects of  the Commission on 
Measles and Mumps, Board for the Investigation of Influenza and other Epidemic Diseases, 
Preventive Medicine Service, Office of the Surgeon General, United States Army, and under a 
contract recommended by the Committee on Medical Research, between the Office of Scientific 
Research and Development and Harvard University. 
1 Wesselhoeft and Walcott  (3)  have recently emphasized the importance of mumps as a 
military disease and discussed its control. 
A preliminary report of certain of these observations has been published (10,  11). 
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questions and which represent the basis for the investigations in human beings 
to  be subsequently  reported.  The  aims  of  this  experimental  work were:  (1) 
to establish  an infection with mumps virus in M. mulatta and  to maintain the 
virus by serial passage,  (2) to determine whether evidence of humoral immunity 
could  be  obtained  following the  recovery of  this  animal  from mumps,  (3)  to 
ascertain whether active immunity could be induced by inoculation of material 
containing the virus which has been inactivated by suitable procedure,  (4)  to 
determine  whether  human  convalescent  serum  possessed  neutralizing  pro- 
perties  for the virus  of mumps. 
Materials and Methods 
Monkeys.--M. mulatta has been exclusively employed.  Animals of different size and age 
have all been successfully inoculated.  Furthermore, no difference in susceptibility associated 
with sex was observed. 
Virus.'Initial infection of the monkey was accomplished by the method of Johnson and 
Goodpasture (4).  Saliva was collected from patients with the classical signs of mumps during 
only the 1st or 2nd day of the disease.  Both Johnson and Goodpasture (4) and Findlay and 
Clarke  (12),  who confirmed the work of the American authors,  were unable to produce in- 
fection with specimens taken  after the 2nd day.  The patient was induced to expectorate 
into a  container at intervals during a  period of about 2 hours.  The saliva was either im- 
mediately brought to the laboratory or kept overnight in the ice box before transportation 
when it was then mixed with an equal quantity of infusion broth.  The mixture was either 
inoculated at once or stored for varying periods in a  CO~. ice cabinet.  About 2 ml. of the 
mixture was injected into the parotid gland of a  monkey v/a Stensen's duct,  employing for 
this purpose a 24 gauge hypodermic needle from which the point had been removed. 
The gland was usually excised on the 4th or 5th day following inoculation.  Since it was 
desired to preserve the monkeys for subsequent study, parotidectomy was carried out under 
ether  or  nembutal  anesthesia.  The  animals  usually  made  an  uneventful  recovery  with 
merely paralyses of certain of the muscles of the cheek and eyelid as permanent residua.  Both 
#ands  were removed during the same operation with no incapacitating sequelae. 
The gland was at once weighed, minced by means of scissors, and ground in a mortar with 
alundum.  Sufficient saline (0.85  per cent NaC1) was added to give a  suspension  containing 
20 per cent of tissue.  The material may be stored in glass-sealed  pyrex ampoules in a  car- 
bon dioxide ice cabinet where its capacity to infect M. mulatta is preserved for 10 months. 
For passage, the 20 per cent suspension was usually diluted with one to five parts of infusion 
broth and the mixture inoculated as described above.  One ml. of a 0.6 per cent suspension  of 
gland has caused infection in the monkey.  The minimal infecting dose has not been de- 
termined. 
Materials of the Complement Fixation Test.--All dilutions are recorded as the final dilution 
of the reagent before the addition of sensitized cells unless otherwise indicated.  This notation 
appears  to be desirable for reasons which one of us has previously emphasized  (14).  The 
materials and technique employed in the complement fixation test are essentially the same as 
previously described (10).  Certain modifications have been introduced with the purpose of 
conserving antigen. 
Preparation of Antigen.--One volume of a 20 per cent suspension  of parotid is diluted with 
5 volumes of saline and  rotated for 30  minutes at 3500 lz.P.M, in an angle centrifuge.  The 
lipoidal material which floats on the surface and the sediment are discarded.  The superna- 
tant fluid was used as antigen in most of the earlier experiments reported in this and the fol- J. 1  ~. ENDERS, L. W. KANE, S. C0!q[EN~ AND ]. ]~. LEVENS  95 
lowing two papers.  It is now, however, our practice to determine the capacity of a  given 
glandular suspension to fix complement in the presence of either monkey or human serum 
known to contain antibody, since it has been found that various lots may vary considerably 
in their content of antigen.  This is accomplished by determining the highest dilution in 
saline of the original suspension of gland which gives complete fixation with 3 strongly positive 
convalescent sera in dilutions of 1:24.  As controls for non-specific fixation 3 sera known not 
to contain antibody are included to which are added the same dilutions of suspension.  The 
positive sera must give "2+  fixation" in a dilution of at least 1:384 with an antigen diluted 
1:113 or one which has been previously standardized by this method.  For use in the com- 
plement fixation test,  twice the concentration of antigen giving complete fixation with at 
least 2 of the 3 positive sera in the titration is employed. 
To control further the specificity of the reaction an emulsion of the parntid gland from a 
normal monkey prepared in the same manner as the infected parotid is employed.  This is 
used in a  dilution equivalent to  that of the infected parotid. 
Sera.--Blood  obtained from the femoral vein of the monkey is allowed to clot; the serum is 
collected and heated at 62°C. for 20 minutes to inactivate complement and remove non-spe- 
cific complement-fixing  properties.  Following the method of Casals and Palacios (13) when 
human sera are used, they are heated at 60°C.  for 20 minutes.  For preservation, sera are 
usually stored at 4°C.  in tubes closed with rubber or cork stoppers.  If monkey sera are 
anticomplementary, it has been found that this property may be completely removed in most 
instances by heating the serum at 62°C.  for 20  minutes, preparing the requisite dilutions 
and,  after allowing them to stand overnight at 4°C., heating them again  at  62°C.  for 20 
minutes.  This procedure has been found not to affect the antibody content of the serum. 
Human sera are double heated at 60°C.  It is usually possible to remove the anticomplemcn- 
tary effect by double heating without dilution, allowing a  2 hour interval at 4°C., but this 
procedure is occasionally not as effective. 
Hemolytic System.--To  one volume of a 2 per cent suspension of thoroughly washed sheep's 
cells, one volume of diluted anti-sheep cell rabbit serum containing 2 units of amboceptor is 
added 15 minutes before the sensitized cells are used in the test. 
Complement.--Sera  from at least 6 guinea pigs are collected and pooled.  This material is 
preserved in the CO2 cabinet until exhausted.  No diminution in complement titer has been 
observed under these conditions during a period of at least 2 months.  The complement is 
aIways fitrated on the day of the test. 
The Complement  Fixation  Test.--Appropriate  twofold dilutions in saline of the inactivated 
serum  to  be  tested are prepared.  Usually these dilutions range  from  1:6  to  1:384.  To 
0.125  ml.  of each dilution of the serum to be tested, 2 units of complement are added in a 
volume of 0.15 ml. and then 0.1 ml. of the antigen.  The mixtures are placed overnight in the 
ice box at 4°C.  and 0.25  ml. of sensitized sheep's cells added to each the following morning. 
Results are recorded after one half hour at 37°C. in the water bath.  The endpoint is taken as 
the last dilution giving definite fixation of complement denoted as 1  +.  Complete fixation is 
denoted as 4+. 
The following  controls are included in each test: 
1.  Unknown serum alone (lowest dilution used in test) 
2.  "  "  and 2  units of complement 
3.  ' .....  1.3  ...... 
4.  2 units of complement 
5.  1 unit  " 
6.  Unknown serum, 2 units of complement, and normal parntid gland suspension 
7.  Normal parotid gland suspension and 2  units of complement 
8.  "  "  "  "  "  1.3  "  "  " 
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10. Infected parotid gland suspension and 2  units of complement 
11.  "  "  "  "  "  1.3  "  "  " 
12.  "  "  "  " 
13.  Salt  solution 
14. A number of  dilutions  of  a known positive  serum sufficient  to  cover  the  endpoint  range. 
To these  are  added infected  parotid gland  suspension and 2 units  of  complement.  The usual 
controls  for the anticomplementary effect  of the serum and the normal parotid gland sus- 
pension are included. 
15. A known negative serum diluted 1:6,  infected  parotid gland suspension,  and 2 units 
of complement. 
Mtcr the addition  of  saline  to  bring the volumes to equivalence  with those of the test,  the 
control  tubes are  maintained  under the same conditions  and each  receive  0.25  ml. of  sensitized 
sheep's cells. 
EXPERIMENTAL 
Mumps in M. mulatta 
Infection of the Monkey ~th Saliva fro~ Cases of Mumps.--The disease which 
we have produced in M. mulatta resembles in all essential respects that described 
by Johnson and Goodpasture (4) and by Findlay and Clarke (12).  Evidence 
of infection has been obtained following the inoculation of 5  batches of saliva 
collected in the city of Boston. 
The first 4 specimens were derived from  4 different  individuals, the last consisted  of a 
pooled saliva supplied by 4 patients.  The criteria of infection consisted in: 
(1)  Definite swelling of the parotid gland after 5 to 8 days; (2) transfer of the disease to 
another animal by inoculation of the parotid tissue; (3) demonstration of specific complement- 
fixing antigen in the infected parotid; (4) demonstration of the development or presence of 
complement-fixing  antibody in the serum during convalescence. 
Infection was demonstrated in the case of the first specimen by criterion 4, in that of the 
second by all 4 criteria.  This latter strain of virus designated as the stock virus has been 
employed almost exclusively throughout the course of our investigation.  In the third spec- 
imen of saliva the virus was revealed by criteria 1 and 4, in the fourth by Nos. 3 and 4, and 
in the fifth by No. 4.  In addition to this evidence for the nature of the virus with which we 
worked is the fact that both experimental and accidental mumps in the human being has 
resulted from inoculation of material from the  11th  monkey passage of the second  strain 
(15,  16). 
Complement fixation tests employing 1 strain of virus as antigen and conva- 
lescent  sera  from  monkeys  infected  with  the  first  4  specimens  of  saliva 
mentioned above have given no indication that any of these viruses possessed 
different antigenic characteristics capable of being revealed by this reaction. 
It is true that the specimens were  collected in one geographical area but,  as 
will be shown in subsequent communications  (15,  17), our stock virus caused 
the fixation of complement in the presence of high dilutions of sera obtained 
from  epidemics of mumps  which  occurred in Wisconsin and  in Philadelphia. 
These findings, together with  the fact that second attacks of the disease are 
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Signs of Infection in the Monkey.--The  gross  signs of  parotifis which resembled  those 
described by Johnson and  Goodpasture  (4),  consisted of enlargement of  the gland as  de- 
termined by palpation and edema of the surrounding tissues.  These manifestations have 
been observed by us to occur in a group of 5 monkeys from the 5th to the 8th day after ino- 
culation.  Following the establishment of serologic criteria of infection, it has been our usual 
practice to remove the glands on the 5th or 6th day after inoculation.  We have, therefore, 
relatively few animals in which these symptoms have been allowed opportunity for greatest 
development.  Our observations, however, are sufficient to indicate that these signs in differ- 
ent animals may vary in their intensity and occasionally may be so ill defined as  to leave  the 
observer in doubt as to whether infection is present.  Minimal edema and parotid hypertrophy 
have been in our experience characteristic of the infection following the inoculation of saliva 
derived from cases of mumps.  In only 3  animals which received saliva, however, has the 
period of observation been adequate. 
In accordance with the statement of Findlay and Clarke (12), we have not remarked in 
monkeys,  inoculated into  1 gland only,  obvious signs of involvement of  the uninoculated 
contralateral gland.  In  I  animal,  however,  inoculated into the left parotid only, comple- 
ment fixing antigen was demonstrated in considerable quantity in both glands.  This single 
observation can merely suggest that spontaneous infection of  the uninoculated gland may 
occasionally ensue. 
Weight and Size of the Infected Gland.--The weights of infected parofid glands have varied 
considerably.  From 18 monkeys, 29 parotids have been weighed on an average of 5.2 days 
after inoculation.  All these glands were shown to contain virus  either  by subsequent  in- 
oculation into a normal animal or by the demonstration of the antigen. 
The smallest gland weighed 2.1 gm. and the largest 9 gm.  The mean weight was 5.2 gm. 
In 10 animals of the group, both glands were inoculated.  In these cases the glands from the 
same animal were found to be of approximately the same weight.  Many were excised on the 
4th or 5th day following the inoculation and accordingly may not have reached the state of 
maximal enlargement.  However, an infected gland removed on the 7th day weighed only 
2.6 gm.; 3 on the 6th day weighed 2.3, 2.8, and 3.2 gm. respectively.  In contrast the largest 
gland encountered, 9 gm., was obtained on the 5th day.  That the weight of the infected 
gland may not be significantly increased at a time when much virus is presumably present was 
shown by an experiment in which only 1 gland in a pair of monkeys was inoculated but both 
glands removed from each on the 6th postinoculative day.  The inoculated gland from  1 
weighed 2.3 gin. and the uninoculated gland 2.6 gm.; the corresponding glands from the other 
weighed 2.8 and 2.1  gm. respectively.  In the uninoculated glands no antigen could be dem- 
onstrated, whereas in the inoculated glands titers of  1 : 1200  and  1:600 were  observed.  We 
must conclude, then, that the weight may not increase markedly following infection although 
in most instances the size of the organ, as judged by palpation, appears to do so. 
Again these observations are not in complete agreement with those of Johnson and Good- 
pasture (4) who recorded a  regular increase in weight of infected glands.  In our experience 
there has been a more definite correlation between the size of the animal and the weight of the 
gland than between the infected state and weight.  For the production of the maximal quan- 
tity of virus, therefore, one should select large animals.  This fact from a practical standpoint 
is of importance.  Since the parotid gland of the monkey is so far the only available source 
of the mumps virus, and since considerable amounts of material for antigen and possibly 
vaccine may be required  (16), it is essential that the optimal yield be obtained from each 
animal. 
The Quantity of Antigen in the Parotid Gland at Various Periods after Inocula- 
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TABLE  I 
Titers of Complement-Fixing AntCgen in Parotid Glands of M. mulatta 
Days after infection 
4  5  6  7  8 
290  290 
>225 
150~ 
15oj 
150~ 
15oj 
6O0 
150} 
290 
290~ 
290  / 
75* 
290\ 
290J 
150~ 
29oj 
29O 
150 
2,400~ 
1,2ooj 
>800 
600  60o} 
29o~ 
290J 
213~ 
29oj 
290\ 
150J 
,  113\ 
15oj 
>225* 
1,200 
600 
150\ 
15oj 
600 
150 
1,200 
600 
150" 
106~ 
150j 
600 
150" 
The titer is expressed as the reciprocal of the highest dilution of parotid suspension giving 
complete fixation with excess antibody. 
The bracketed figures are the titers obtained  from the left and right glands of the same 
animal. 
* Glands removed from the same animal. 
Table I  shows that the complement-fixing antigen may be present in consid- 
erable  amount  within  4  days  after  inoculation  of the  gland.  The maximal 
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At this time, it should be emphasized, the fully developed signs of mumps 
were not yet present in most animals.  Although we cannot state whether or 
not  viral  infectivity parallels concentration  of complement-fixing antigen,  a 
quantitative  relationship  of this  sort  would  seem  on  a  priori  grounds  to  be 
probable.  If it does obtain, the maximal quantity of virus would have devel- 
oped  in  the  gland  at  a  time previous  to  the  occurrence  of the most  intense 
reaction on the part of the host's tissues.  Phenomena  of this sort have been 
observed  with  other  viruses.  For  example,  the  infective  and  complement- 
fixing titers of influenza A virus reach maxima inthe lungs of mice 2 to 3 days 
after inoculation whereas  the pneumonic  consolidation is not  marked  before 
the 4th or 5th day (18,  19). 
The results recorded in Table I  also are of interest since they make it clear 
that  very  considerable  quantities  of  the  antigen  may  be  produced.  Thus 
complete fixation of complement has been obtained with one suspension diluted 
1 : 2400 and glands from a number of other animals gave yields only slightly less. 
The average titer of the glands excised on the 5th and 6th days is about 1:400. 
We have  alluded to  the presence  of the  complement-fixing antigen  in  the 
gland with the implication that the detection of this factor constitutes evidence 
of infection.  In view of the facts just presented taken together with observa- 
tions which will be described, there would seem to be no ground for questioning 
this  assumption  since  (a)  the  antigen  has  been  found  only in  animals  after 
inoculation with  the virus,  (b)  has  never been  demonstrated  in other tissues 
of infected monkeys such as spleen, pancreas, brain, and testicle or (c)  in the 
parotid gland of normal animals, and  (d) reacts specifically with an antibody 
which  is not present in normal animals,  but  which  appears  regularly during 
convalescence.  3 
The White Blood Count.--Johnson and Goodpasture (4) noted a decrease in the leucocytes 
with a relative and absolute increase in the number of round cells,  These changes occurred 
just before the development of local signs.  We have performed daily white counts and a few 
differential counts on a number of animals. 
In a group of 5 monkeys definitely shown to have undergone an infection some fall in the 
total white cell count was observed in every case.  This usually occurred  just before  and 
during the time of obvious mumps,  that is, from  the 6th to the 8th  day after inoculation 
although in 3 animals some decrease was noted as early as the 3rd or 4th day.  In 2 instances 
the decrease was about 50 per cent of what might be regarded as the normal count; in the other 
3 it was only of the order of 20 to 30 per cent.  One animal which was reinoculated with 
active virus following recovery, and in which white blood counts were taken, also showed a 
slight but definite decrease on the 5th day.  Another monkey inoculated with egg material 
gave no definite evidence of infection yet exhibited a decrease in the total white count of 35 
per cent on the 3rd and 4th days. 
Because of these findings and additional observations made during a study of measles in the 
monkey on the marked variation which may occur in the total and differential counts of the 
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normal animal, we conclude that although infection with the virus often may induce a fall in 
the number of circulating white blood cells, the determination of the count is of little value as 
a criterion of infection.  Accordingly in our more recent experiments we have not sought it as 
an aid in diagnosis, depending rather on the demonstration of antigen in the gland or antibody 
in the serum. 
Rise in Body Temperature.--Equally unsatisfactory has been our experience with a rise in 
body temperature as an idex of infection.  In only 1 animal of 14 in which daily temperature 
readings were recorded and in which either the antigen or development of antibody was de- 
monstrated did the temperature reach 104°F.  Moreover,  excepting in that single animal, the 
difference in readings for each individual was not greater than about 1.5°F.  Johnson and 
Goodpasture, however, frequently noted temperatures  of  104°F. during the course of the 
infection.  The discrepancy may possibly be due to the existence of strains of virus differing 
in pyrogenic capacity; but in any event we are inclined to regard a rise in body temperature, 
like leucopenia, as irregularly associated with the disease. 
ttistology of the Inoculated Gland.--Johnson and Goodpasture (4) and Bloch (20) have de- 
scribed the histologic changes induced in the parotid gland as a result of experimental infection 
with the virus.  We have examined the glands from 7 monkeys removed at periods varying 
from 5 to 9 days following  inoculation.  Included in this series was 1 animal which received a 
filtered suspension of infected parotid shown to be sterile by suitable methods of cultivation. 
In every instance except in the gland removed on the 9th day when obvious signs of mumps 
had almost completely subsided, all the appearances considered by the authors just mentioned 
as being characteristically caused by the activity of the virus were observed.  Glands from 
4 normal monkeys and from 1 animal inoculated with the virus of poliomyelitis did not ex- 
hibit these pathological changes. 
The Development of Complement-Fixing Antibody  Following Inoculation with the 
Virus of Mumps 
In a preliminary report (10) evidence has been presented which shows that 
antibody capable of fixing complement in the presence of a  suspension of the 
infected parotid gland appears in the serum of monkeys recently convalescent 
from experimental mumps.  Since the publication of  this communication, a 
large number of animals have been studied.  The results of tests on the sera 
of 11 monkeys bled before inoculation with the virus and at various intervals 
thereafter are presented as examples in Table II.  From this material and many 
other determinations not recorded in detail, several facts emerge:- 
The Absence of Antibody  in the Sera  of Normal Monkeys and the Occurrence 
of  Inapparent  Contact fnfections.--The  complement-fixing antibody  is  not 
usually present in the sera of monkeys before inoculation with the virus.  The 
sera obtained from 47 presumably normal monkeys were tested.  Even in low 
dilutions (1:6 or  1:12)no antibody was demonstrated in 42  animals.  With 
the sera of the remaining 5  animals, fixation occurred. 
But it was  not until many monkeys had been studied that antibody was 
encountered in an animal which was supposedly normal.  Since the antibody, 
however, appeared to be specific and since it was known that the animals most 
recently studied had been housed for considerable periods of time in the same 
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of these contacts might have undergon~ inapparent infections.  An experiment 
was undertaken in which a  normal monkey of a  recent shipment was kept in 
the same cage with an  animal which had  been inoculated with virus.  Com- 
plement-fixing antibody could not be demonstrated in the serum of the normal 
TABLE II 
The Development of Complement-Fixing Antibody in the Serum of M. mulatta Following 
Infection with the Virus of Mumps 
Monkey 
1 
43 
19-37 
5 
21 
22 
Test done 
before  Test done during 
inoculation or  early convalescence  during 
acute stage 
Test done 
after recovery 
Time  Time  Time 
after  Titer*  after  Titer~/  after  Titer~/ 
inocu-  inocu-  inocu- 
lation  lation  lation 
days  days  months I 
0  0  22  21705  2  275 
0  0  13  1024  7  96 
7  0  18  1024  3  185 
0  0  13  1536  3  185 
0  0  13  3072  3  192 
0  0  13  384  3  <6 
19-35A  0  0  19  >1024  1  1024 
19-38  0  0  --  nd  1~  185 
6  --  rid§  18  I095  10  24 
17  --  nd  --  nd  4  12 
19-34  --  nd  --  nd  21  17 
Remarks 
A  1:24  dilution  of serum gave 
tr reaction with the 3 too. sped. 
men. 
A 3+ reaction was obtained  wit~ 
early  convalescent  serum in di. 
lution recorded. 
This animal  was  inoculated  wit[ 
saliva.  Titer 3 mos. after inocu. 
lation was 180. 
* In the majority of cases initial  dilutions  of 1:2 were tested.  In the other instances 
initial dilutions  of 1:4 were the lowest tested. 
:~ Reciprocal of final dilution  of serum giving 1  +  fixation.  In certain  instances the end- 
point was calculated by determining the geometrical mean between the dilution giving greater 
fixation than 1+ and the next lower dilution giving less than l+. 
§nd, not done. 
monkey before  the  experiment was  begun.  Contact  was  maintained  during 
the  5  days  following the  inoculation of  the  other monkey  when  the  normal 
monkey was placed in a  cage by itself and was observed for 50 days.  During 
this  time specimens  of its  serum  were  tested.  No  indication  of disease  was 
noted  but  antibody  was  found  in  the  serum  34  days  after  initial  exposure. 
It  was  not present  on  the 3rd,  5th,  6th,  9th,  and  19th  days  after  exposure. 102  IMMUNITY  IN MUMI~S.  I 
Following challenge inoculation with virus,  antigen was  not  revealed in the 
glands.  This result indicates that in the monkey contact infection can occur 
which is inapparent in form but leads to the emergence of antibody and the 
establishment of resistance.  After this experiment was completed, 2 monkeys 
kept in  the  same  room with  recently infected animals  developed antibody. 
They too proved refractory to inoculation of virus. 
Johnson and Goodpasture (4)  did not observe any signs of disease in their 
normal animals which were in contact with those which had been inoculated, 
and so concluded that infection did not take place in this manner.  From our 
experience it would seem that under such conditions infection does occur.  The 
necessity, therefore, of maintaining infected animals in quarters separate from 
those occupied by normal monkeys is obvious. 
Time of the Appearance of Antibody and Its Persistence Following Recovery.- 
Antibody  may  appear  in  the  serum  within  a  short  time  after  the  virus 
is injected.  Thus in 1 animal a titer of 1:96 was demonstrated on the 8th and 
in another on the 9th day.  In other cases such as M19-37 alluded to in Table 
II, no antibody was demonstrable in the late acute stage.  By the 13th to 15th 
day, however, the  antibody is usually present in high  concentration and  at 
about  this  time  the  maximum  is  probably  attained  as  is  indicated  by the 
results summarized in Table II and the records of successive determinations 
of antibody in the same animal such as that presented below in the protocol 
for monkey 20-47.  The protocol also reveals that a  rapid and extensive in- 
crease in  concentration occurs once  the  antibody has  made  its  appearance. 
Similar abrupt rises in antibody levels have been noted in certain human beings 
during  the  convalescence and  will  be  reported in  the  second paper  of  this 
series (15). 
l~rotocol/.--Monkey  20-47.  Mar. 30, 1944.  Inoculated into both ducts of Stensen with 
1 ml. of 1:40 dilution of suspension of infected gland of the llth monkey passage.  Apr. 4, 
1944.  Both  glands  removed  under  ether  anesthesia.  The  right  gland  completely  fixed 
complement in a  dilution of  1:300 and the left in a  dilution of  1:150.  At various times, 
samples of serum were taken and titrated for antibody. 
Reciprocal of highest dilution 
Date blood  of serum giving fixation of 
drawn  complement 
3/23/44  No fixation (serum diluted 6) 
3/31/44  ....  (  ......  ) 
4/  4/44  ....  (  ......  ) 
4/  5/44  ....  (  ......  ) 
4/  6/44  ....  (  ......  ) 
4/  7/44  96 
4/10/44  >96 <128 
4/11/44  384 
4/13/44  >384  <1536 
4/15/44  >384 <1536 
4/17/44  >384  <1536 
4/19/44  >384 <1536 J. F. ENDERS,  L. W. KANE,  S. COHEN~ AND J. H. LEVENS 
Reciprocal  of highest  dilution 
Date blood  ol  sc:um  giving  fixation  of 
drawn  complerncnt 
4/24/44  1536 
4/28/44  1536 
5/ 2/44  384 
5/ 5/44  384 
5/12/44  384 
5/20/44  96 
5/25/44  96 
7/31/44  >48 <96 
8/29/44  >48 <96 
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A  high concentration of antibody may be retained for about  1 month; but 
by the 2nd or 3rd month after inoculation the titers usually declined from the 
early convalescent level by at least a  factor of  5. 
From the results obtained with the sera of monkeys 6 and 19-34 (Table  II) 
and  M  2047  (protocol),  it  is  evident  that  antibody  may  persist  for  many 
months.  The titers of antibody recorded at 10 and 21 months are of approxi- 
mately the same magnitude as those encountered in the sera of normal human 
beings who give positive complement fixation tests  (17).  Furthermore,  they 
are  comparable  to  the  titers  of  the  sera  of most  persons  convalescent from 
mumps which have been drawn at analogous periods following the disease (15). 
The Regularity  of Antibody  Formation  Following Infection.--Following  the 
intraparotid inoculation of virus, antibody has appeared de novo in the serum 
of  19  normal  monkeys  which  have  been  studied.  In  no  instance  have  we 
failed to demonstrate its formation when the test has been carried out at the 
appropriate time.  This  uniformity of response  shows  that  the  existence  of 
antibody in the monkey is a  reliable index of previous infection.  From the 
results of similar studies on mumps in human beings (15), the same regularity 
of antibody formation has been demonstrated. 
Properties of the Complement-Fixing Antigen 
Thermostability.--Experiments have  shown  that  the antigen in suspensions  of infected 
glands responsible for the fixation of complement  in the presence of the specific antibody is 
moderately resistant to heat.  The thermostability of the antigen at two temperatures in 
varying hydrogen ion concentrations was investigated. 
Suspensions of infected gland (3.3 per cent) were prepared in a series of isotonic phosphate 
buffers at pH 5.2, 5.9, 6.4, 6.7, and 7.5.  The preparations were maintained at 37°C. for 2 
hours when flocculafion of protein was observed at pit 5.2.  After adjustment of the reaction 
to pH 7, a portion of each preparation including the precipitate and supernatant fluid of that 
at pH 5.2 was tested for capacity to fix complement.  Other portions were heated for an ad- 
ditional period of 20 minutes at 65°C.  Under these conditions a varying degree of flocculation 
was noted in all, being most abundant at the more acid reactions.  The precipitates were 
resuspended in buffer at pit 7 and the supernatant fluids adjusted to the same hydrogen ion 
concentration.  They were then employed as antigens in the complement fixation test.  The 
results showed that in the range pH 6.4-7.5  the antigen, all of which remained in the super- 
natant fluid, was unaffected at 37°C. for 2 hours followed by further heating at 65°C. for 20 104  rM%4~'NITY IN W[IYMPS.  I 
minutes.  At the most acid reaction activity was reduced at 37°C. but was not entirely elim- 
inated at 65°C.  This residual activity was associated with the precipitated protein. 
Maintenance of Activity during Storage.--After  standing for 1 week at room temperature 
(18-20°C.),  the original titer of a  20 per cent suspension of the gland was reduced about 
one-half.  The titer of a  20 per cent suspension remained unchanged for 12 months in the 
COs ice cabinet.  The titer of a 6.6 per cent suspension of the gland also remained constant 
16 days at 4°C. and was only slightly reduced after 45 days.  It is therefore unnecessary to 
prepare the antigen for each test from material which has been stored in the COs cabinet. 
The Effect of Formalin.--In  view of the possible use of formolized virus as a vaccine, the 
effect of various concentrations of commercial formalin on the activity of the antigen was 
investigated.  To 5 portions of a 1:30 suspension of the gland in saline, sufficient formalin to 
give concentrations of 0.5, 0.4, 0.3, 0.2, 0.1 per cent was added and the preparations allowed to 
stand at 4°C. for 3 days.  Analogous preparations of normal parotid gland suspension were 
kept under the same conditions as controls.  Titrations were then carried out which indicated 
that none of these concentrations of formalin appeared to impair the activity of the antigen. 
Indeed the endpoints in every instance were slightly greater than that found for the material 
without formalin.  This enhancing effect was probably due to a  slight anticomplementary 
action of the formalin. 
Attempts were also made to evaluate the effect of 0.5 per cent phenol which has been used 
as a  preservative in material for the skin test (15,21).  The suspensions, however, of both 
normal and infected gland were rendered so anticomplementary by its addition that titrations 
proved impracticable. 
Filtrability of the Antigen.--When a 20 per cent suspension of infected gland in saline was 
passed through an Elford collodion membrane of about 500 m9 A.P.D. under approximately 1 
atmosphere positive pressure,  complement-fixing antigen was  found  to  be present in  the 
filtrate.  Under these circumstances, however, only about one-eighth of the antigen traversed 
the membrane.  It is probable that the inefficiency of filtration was due to the nature of the 
suspending medium as it is well known that in solutions of sodium chloride various viruses do 
not pass through filters the pore sizes of which are much larger than the particles of virus.  We 
have not employed broth as a medium since it has been found to exert an anticomplementary 
effect. 
Deposition of Antigen in the Ultracentrlfuge.--A 20 per cent suspension of infected gland was 
prepared in phosphate buffer at pH 7.2 and cleared of large particles by centrifugation at 
3500 mP.~. for ½ hour in the angle centrifuge.  Approximately 5 ml. of the superuatant fuid 
were then rotated in the ultracentrifuge for 1½ hours at 220,000 X  gravity.  The supernatant 
fluid was removed in 3 portions of 2 ml., 2 ml., and about 1 ml.  The small amount of material 
in the bottom of the tube was suspended in 4 ml. of phosphate buffer.  These specimens were 
tested for their capacity to fix complement in the presence of mumps antibody.  No activity 
was demonstrated in the upper portions of the supernatant; a slight fixation was observed with 
the 1 ml. portion.  The material recovered from the base of the tube was found to have a 
titer of the same magnitude as that of the suspension before centrifugation.  It can therefore 
be stated that the complement-fixing antigen is almost completely separated from the sus- 
pending medium under the conditions described. 
Failure to Demonstrate Other Serologic Reactions with the Antigen.mhttempts were made to 
demonstrate flocculafion in the presence of antisera of high titer.  In no instance was any 
indication of a phenomenon of this sort observed.  Following the suggestion afforded by cer- 
tain reports on the agglutination of collodion particles (22) and bacteria (23) to which various 
viruses were adsorbed, we carried out similar experiments with suspensions of infected gland 
and homologous antibody.  Again the results were entirely negative. 
Failure to Demonstrate  Hemoagglutination by the Antigen.--The peculiar property of certain 
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vaccinia (27)  to cause the agglutination of erythrocytes has recently been described.  Ac- 
cordingly the effect of the mumps antigen on the red cells of a number of species of animals was 
investigated.  The latter included man,  monkey,  rabbit, sheep, horse, ox, guinea pig,  and 
fowl.  No hemoagglutination was observed in any case. 
Failure to Demonstrate Elementary Bodies in Suspensions of Antlgen.--Darkfield  examina- 
tion as well as smears of suspensions of potent antigens stained by the method of Herzberg 
(28), Giemsa, or Macchiavello's technique (29) have presented no appearances which might 
be interpreted as elementary bodies. 
Properties of the Complement-Fixing  A ntibody 
In  the  following  account  of  certain  properties  of  the  complement-fixing 
antibody we have included data derived from the study of the antibody which, 
as will be shown in subsequent papers, appears regularly in the serum of human 
beings  convalescent from mumps and  in that  of certain normal  individuals. 
Although we are here concerned with immunologic phenomena of the infected 
monkey, it seemed most convenient to introduce this material at this  point. 
Thermostability.--The  titer of the antibody in monkey serum remains unchanged when th  e 
serum is maintained at 62°C. for 20 minutes.  When the undiluted serum or dilutions thereof 
after cooling at ice box temperatures are again heated under these conditions, no significant 
decrease in the concentration of antibody is observed.  This fact has proved of great practical 
value since it has been found that double heating of a serum which is anticomplementary re- 
moves this effect in most instances.  4  It has therefore been possible to use sera in the com- 
plement fixation test which have become anticomplementary on storage.  The procedure of 
double heating is also applicable to human sera;  but the antibody appears to be less ther- 
mostabile since heating for 20 minutes at 62°C. appreciably reduces the titer.  At 60°C. for 
20 minutes, however, the antibody is not affected and the procedure of double heating may be 
employed under these conditions.  When heated at 65°C. for 20 minutes much of the antibody 
in both human and monkey sera is inactivated. 
Maintenance of Activity during Storage.--Anfisera  of both human and simian origin to be 
employed for the standardization of antigen have been maintained in the frozen state in the 
COs cabinet; no demonstrable change in titer has occurred even after 6 months.  If the means 
are available, this procedure would seem to be the simplest way to store antisera when it is 
desired to insure the preservation of the antibody.  When it is necessary, however, to keep 
large numbers of specimens, this method may not be convenient, and recourse must be had 
to the ordinary ice chest.  Comparative studies on 61 human sera kept at 4°C. have shown 
that  the concentration of antibody may  decrease rather rapidly.  A  number exhibited a 
diminution in titer after 2 months whereas after 8~ months in certain instances in which the 
initial titer was not high, no antibody could be demonstrated.  Fewer data of the same sort 
are available for monkey sera.  Determinations, however, of the antibody before and after 
storage at 4°C. have shown it is much more stable. 
The  instability of the mumps complement-fixing antibody in human serum, contrasting 
with the stability of similar antibodies for other viruses such as influenza, should be borne in 
mind if specimens submitted to the laboratory for diagnostic test have been preserved for any 
significant length of time.  It is also evident that human sera to be used for the titration of 
antigens should not be stored in the ice chest but maintained in the frozen state. 
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The Association of the Antibody with Gamma Globulin.--The  quantity  of the 
mumps  complement-fixing  antibody  in  specimens  of  concentrated  human 
globulins  prepared  by  Cohn  and  his  associates  from  large  pools  of  normal 
human  plasma  has  been  determined  (30).  The  results  have  shown  that  in 
man the antibody  is largely associated with the gamma globulin fraction.  In 
this fraction a  concentration of the mumps antibody of 20 to 30 times over the 
plasma  has  been  regularly  recorded.  A  gamma  globulin  fraction  prepared 
from a  pool of convalescent mumps plasma  by  the  method  employed  for  the 
normal plasma  exhibited  a  concentration  of antibody  of from  10  to  20  times. 
Since certain  of  the preparations  of globulin  studied  consisted  of  about  90 
to  100  per  cent  gamma  globulin,  it  is  evident  that  the  mumps  complement- 
fixing antibody is closely associated with this serum protein.  That  it is to be 
identified with  the latter  cannot be asserted  on the basis  of the  available evi- 
dence,  but  this hypothesis  appears  reasonable. 
Failure to Produce Infection  or to Demonstrate the Antigen in the Organs of 
the Monkey Other Than the Parotid and in Certain Tissues 
of Other Animal Species 
Two male monkeys, 1 an adult, the other a young animal, were inoculated intratesticularly 
with the virus.  The testes were removed on the Sth and 4th days respectively.  Saline sus- 
pensions of the glands were tested for antigen.  None was found although in both animals the 
parotid glands which had been inoculated at the same time as the testes yielded the usual 
quantity. 
To determine whether antigen might be produced in the brain, a normal monkey was in- 
jected into the mid-cerebral area with 0.3 ml. of a 20 per cent suspension of infected parotid 
gland.  Five days later portions of the brain were removed and prepared as antigen according 
to the method of Casals and  Palacios  (13).  Again no evidence was obtained of the pres- 
ence of antigen nor was it detected in a sample of the spinal fluid of the same animal. 
Employing the method of inoculation v/a the parotid duct, 3 young cats estimated to be 
about 2 to 4 months old were given 0.5 ml. of 20 per cent infected gland.  After 2, 5, and 6 
days respectively, emulsions of the glands were tested.  No antigenic activity was noted, nor 
did complement-fixing antibody subsequently develop.  These negative findings would appear 
to afford evidence against the belief that cats are susceptible to the virus of mumps,--a belief 
established, presumably, by the experiments of Wollstein (31,  32). 
A number of rabbits and guinea pigs have been inoculated into the parofid, intratesticu- 
larly, intracerebrally, and into the anterior chamber of the eye.  No antigen was detected 
either in the parotid,  testes or brain and no lesions developed in the inoculated eye which 
could be attributed to a specific effect of the virus.  Antibody, however developed in certain 
of those inoculated into the parotid after about 2 weeks. 
Virus was injected into the testes of a mature ferret and the animal observed for 3 weeks. 
No significant rise in temperature nor definite swelling of the inoculated organ were noted. 
No antibody was found in the serum after 21 days. 
An extensive study was carried out in white mice following a result which suggested that 
the antigen increased in the brain after intracerebral inoculation of virus.  Numerous pas- 
sages by this route were completed but the phenomenon was never observed again nor were 
symptoms induced which could be interpreted as due to the virus.  These negative findings 
are in agreement with those of Swan and Mawson  (33).  Antibody was not demonstrated 
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Two cotton rats and 1 hamster were inoculated intracerebrally with potent virus.  The 
animals remained well. 
A dog was given virus v/a the parotid duct.  No swelling of the gland ensued.  The organ 
was not examined for the presence of antigen. 
We have also carried out numerous experiments in attempts to propagate the virus in the 
developing hen's egg.  Inoculation has been effected by various routes including the cho- 
rioallantoic membrane, the chorioallantoic cavity,  the yolk sac,  the amniotic sac,  and the 
embryonic brain.  Injections have likewise been made intravenously employing the mineral 
oil method of Brandly (34, 35)  as modified by Eichorn (36).  Incubation of the inoculated 
embryos has been maintained at both 35  ° and 37°C.  The egg fluids as well as suspensions of 
the chorioallantoic membrane, yolk sac, and embryo were tested repeatedly at varying periods 
following inoculation, hut in no instance has it been possible to demonstrate unequivocally 
the presence of antigenP 
Only once has material from the inoculated egg been tested for the presence of virus by the 
intraparotid inoculation of the monkey.  This animal received into the right parotid duct 
pooled  chorioallantoic membrane suspension of  the 4th egg passage  (37°C.)  and into  the 
left duct pooled yolk sac  material from  the 3rd egg passage  (37°C.).  Antibody  did not 
develop in the serum as a result of these inoculations.  Later, however, following the injection 
of monkey virus the usual antibody response ensued.  This observation is in agreement with 
most of those of Swan and Mawson (33) who employed 10 monkeys in testing materials derived 
from developing eggs inoculated with mumps virus.  In 2 animals, however, these authors 
obtained symptoms compatible with the disease  but subsequently tests for immunity by 
challenge inoculation with monkey virus indicated that 1 of these monkeys remained sus- 
ceptible.  It would seem, then, that if the strains of virus which so far have been studied 
multiply at all in the developing egg, they do so with great irregularity and then only to a 
very limited degree. 
The possibilities of tissue culture were also explored.  The roller tube method was employed 
as adapted to the cultivation of vaccinia virus by Feller, Enders, and Weller (37).  Cultures 
were prepared consisting of (1) chick embryo tissue, (2) various tissues of the monkey such as 
spleen, testis, parotid gland, and (3)  minced human placenta.  Chicken serum was incorpo- 
rated in the nutrient fluid for the embryonic tissue; normal monkey serum for the monkey 
tissues and monkey or human serum shown to contain no antibody for the placental tissue. 
After inoculation with the virus the nutrient fluid and tissues were removed from time to time 
and employed as antigens.  In only i instance was the antigen demonstrable after the nutrient 
fluid had been once replenished and that was in cultures which consisted of the infected pa- 
rotid tissue of the monkey.  There, however, merely survival and not multiplication of the 
virus was demonstrated. 
These results, then, illustrate once again the narrow limits of host and  tissue 
range to which viral increase is confined. 
Experiments on the Active and Passive Immunization of Monkeys 
Vaccination with Formolized Antigens.--The  demonstration  of  considerable 
quantities of antigen in glandular  suspensions together with  the development 
of a  means  of determining in vitro at least  1  type of immunologic response  to 
5 In reply to an inquiry as to whether he had been able to obtain evidence for the multi- 
pllcation of the virus in the developing hen's egg, Dr. Ernest Goodpasture has stated in a letter 
to one of us (J.F.E.)  that he had failed to do so following inoculation of the chorioallantoic 
membrane.  He had not explored the possibility of other routes  of inoculation.  We  are 
indebted to Dr. Goodpasture for this information. 108  rM'MUSII~ IN MIrgPS.  I 
the presence of the virus induced us to  undertake a  series of experiments in 
monkeys designed to show whether or not inactivated virus, when parenterally 
injected, led (1) to the appearance of antibody and (2) to increased resistance 
against subsequent intraparotid infection.  Vaccines were prepared in 2 ways. 
Formollzed vaccine: Sufficient formalin to yield a final concentration of 0.3 per cent was 
added to a 10 per cent suspension in saline of infected gland.  It was found by injecting the 
material into the parotid glands of 2 normal monkeys that after standing for 24 hours at 
4°C. it did not induce infection as judged by the failure to demonstrate complement-fixing 
antigen in the inoculated glands on the 5th day.  In certain cases this 10 per cent suspension 
was employed; in others the material was diluted in saline so that the concentration of gland 
was 2.5 per cent and that of the formalin was 0.075 per cent. 
Alum-precipitatedformolized  vaccine: A 20 per cent suspension in saline of infected parotid 
gland was treated with 0.3 per cent formalin and allowed to stand overnight in the ice box 
when 0.1 ml. of a 10 per cent solution of potassium alum was added for each milliliter of virus 
suspension.  The material was neutralized with NaHCO3 in a concentration of 20 per cent. 
A white colloidal  suspension formed immediately which, after allowing the tube to stand for 1 
hour in the ice box, was sedimented by centrffugation at 3500 R.P.M. in the angle centrifuge. 
Mter removal of the supernatant fluid, the insoluble material was suspended in a volume of 
saline equivalent to the original volume.  This suspension was used as the vaccine. 
The data obtained in 7 experiments in which these vaccines were employed 
are  summarized in Table III.  With  2  exceptions,  2  doses  of  vaccine were 
given subcutaneously at an interval of 5 days.  In 1 instance (M  11)  2 doses 
of  the  formolized vaccine were  injected intracutaneously and  in  the  other 
(M  42)  only 1  dose  of vaccine was  administered.  For complement fixation 
tests specimens of serum were obtained before each dose of vaccine was  given, 
at the time of the challenge inoculation of virus, at the time of parotidectomy, 
and subsequently at various intervals.  To test for the development of  resist- 
ance, active virus was inoculated into 1 or both glands.  The content of antigen 
in  the glands was determined by titration on the 5th or 6th day following.  The 
pertinent facts obtained from the study of animals, which did not receive the 
vaccine but were included in each experiment as controls, are also presented. 
It is clear from the combined results that  12  at least of the  18 vaccinated 
monkeys exhibited moderate titers of complement-fixing antibody at the time 
of inoculation with active virus.  Since it was determined that this antibody 
was not present in 10 of these animals before vaccination and was probably not 
present in the other 2, it is likely that in most instances this factor appeared 
as the result of the injection of the inactivated virus. 
This conclusion,  however, may not be accepted without qualification, since previous contact 
with infected animals cannot in every case be excluded which might have led to the develop- 
ment not only of antibody but also to resistance against the challenge inoculation of virus. 
Such contact is known to have occurred in the case of M 19-39 and is very probable in that of 
the control, M 27.  The latter exhibited no antibody at the time of infection, but 2 days 
afterwards antibody was found in its serum in a titer of 1:384.  This sudden rise so soon 
after inoculation strongly suggests the previous existence of immunity.  The majority of the TABLE  III 
Immunization of Monkeys with Formolized and Alum-Predpitated Formolized Virus 
Experi- 
ment 
I 
I 
II 
II 
II 
III 
III 
III 
III 
IV 
IV 
IV 
IV 
IV 
V 
V 
V 
V 
VI 
VI 
VII 
VII 
VII 
VII 
VII 
Monkey 
19-39 
48 
49 
5O 
1 
9 
10 
11 
12 
23 
24 
25 
26 
27 
29 
30 
31 
32 
34 
33 
37 
38 
4O 
42 
35 
Vaccine dose* 
1--10f 
1--10f 
0.3--10f 
0.3--10f 
0.3--10f 
0.3--10f--ic 
0.5--10f 
0.5--10of 
0.5--2.5f 
O. 5--2.5af 
O. 5--lOaf 
0.5--2.5f 
0.5--2.5af 
0.5--10f 
0.5--2.5af 
0.5--2.5af 
0.5--2.5af 
0.5--2.5af44 
Interval 
between 
1st dose 
of vac- 
cine and 
infec- 
tion 
28 
19 
19 
15 
15 
15 
14 
14 
14 
14 
14 
14 
14 
14 
21 
21 
21 
15 
I  Titer complement- 
Virus doses  fixing  antigen in 
gland§ 
1--5 
1.5--5 
1--5 
5--5 
5, 1--5 
1--10 
1--10 
1--10 
1--10 
1, 1--2.5 
1, 1--2.5 
1, 1--2.5 
1, 1--2.5 
1, 1--2.5 
1, 1--2.5 
1, 1--2.5 
1, 1--2.5 
1, 1--2.5 
1, 1--2.5 
1, 1--2.5 
1, 1--1.3 
1, 1--1.3 
1, 1--1.3 
1, i--1.3 
1, 1--1.3 
R  L 
< 75  ni¶ 
245  175 
< 75  ni 
< 75  ni 
150  >225 
75  ni 
75  ni 
213  600 
290  290 
150  425 
213  213 
53  <38 
<38  <38 
<38  <38 
150  150 
150  105 
<75  <75 
290  213 
150  150 
600  600 
150  75 
75  75 
<38  <38 
> 150  nd¶ 
290  290 
48 
0 
24 
0 
24 
0 
0 
48 
24 
96 
0 
"liter com- 
plement- 
fixing 
antibody 
18 to 30 
d~yes after 
ctionll 
1536 
nd 
768 
1536 
1536 
768 
384 
768 
768 
24 
384 
384 
384 
1536 
384 
nd 
384 
nd 
nd 
nd 
384 
1536 
1536 
736 
1536 
* The first figure indicates the volume of each dose in milliliters of vaccine; the second 
figure refers to the percentage  concentration of infected parotid gland; "f" denotes vaccine 
containing 0.3  per cent formalin; "of"  denotes vaccine  prepared by precipitating the for- 
molized material with potassium alum; vaccine was given by the subcutaneous route except 
in the case of M  11 in which it was inoculated intracutaneously.  With the exception of M 42 
which received 1 dose of vaccine, each of the other animals received 2 doses at an  interval 
of 5 days. 
~t The first and second figures give the volumes of inoculum in milliliters of the right and 
left gland respectively.  The third figure indicates the percentage concentration of  infected 
parotid. 
§ Reciprocals  of  the highest dilution of gland suspension  causing complete  fixation of 
complement in the presence of excess antibody. 
[] Reciprocals of the highest dilution of serum giving +  or ++  fixation. 
4 ni =  "not inoculated"; nd=  "not done." 
** Specimens of serum secured before the first dose of vaccine were somewhat anticomple- 
mentary  or  fixed  complement in  the  presence  of  normal parotid  suspension.  Therefore, 
although it is probable that antibody developed as a  result of vaccination, it is impossible 
to be certain. 
:~:~ This titer was obtained with serum drawn the day following inoculation.  No antibody 
was detected in the specimen taken the day of inoculation. 
§§ 2 days before inoculation the titer of the serum was 48.  It is difficult to account for 
the sudden disappearance of  antibody. 
t[ [] Although no antibody was demonstrated on the day of infection, 2 days later  the titer 
was  > 384.  This observation strongly suggests that the animal had previously been exposed 
to the virus. 
44 Monkey 42 received only a single dose of vaccine. 
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animals were kept in quarters which were remote from those of infected monkeys until the 
time they were employed in these experiments.  Accordingly we are reasonably certain that 
in most of them previous inapparent infection was not responsible for the results.  Further 
evidence of the capacity of such vaccines to stimulate the formation of antibody is afforded by 
the results of experiments in human beings which will be described in a later communication 
(16). 
Since in none  of the animals was  antibody demonstrated  5  days after the 
first dose of vaccine, it might be inferred that a  single injection represented  an 
inadequate antigenic stimulus.  It is possible, however,  that  thi.~  "nterval is 
too short to permit antibody formation.  Thus it is of significance that  M  15, 
which received only 1 dose of vaccine, was found to have developed antibody 
by the 15th postvaccinal day. 
In  determining  whether  or  not  resistance  to  intraparotid  inoculation  of 
virus was induced as a  result of vaccination, we have depended upon demon- 
strating on  the 5th  or 6th  day the absence or presence of complement-fixing 
antigen  in  the  gland.  Because  the  antigen  appears  regularly in  susceptible 
animals which have received quantities of virus comparable to those employed 
for challenge inoculation we believe, as previously stated, that its absence is a 
fairly dependable criterion of resistance.  It has also been shown that convales- 
cent monkeys challenged with active virus fail to develop antigen in the inocu- 
lated gland.  Moreover it seems reasonable to regard titers of antigen which 
are definitely lower than those usually encountered in susceptible monkeys as 
suggestive evidence for some degree of resistance.  Parotidectomy might have 
been  postponed  until  after  the  expected period of  symptoms  thus  affording 
another criterion for estimating the effect of vaccination.  This was not done 
because at that time antigen may have disappeared from the gland.  Moreover, 
as already stated,  the manifestations of parofitis may often be minimal and 
difficult to recognize. 
With  these considerations in mind,  we may proceed  to an  examination of 
the data included in columns 6  and 7 of Table III. 
If the titers of antigen in the glands obtained from the vaccinated animals be compared 
with those derived from the controls, it is found that the frequency  of low values is signifi- 
cantly greater in the former.  Thus in 10 among 16 of the animals which received 2 sub- 
Cutaneous doses of vaccine, the glands showed antigen titers of 1 : 75 or less.  In 5 individuals 
no antigen could be detected in the lowest dilution of suspension it was possible to test without 
encountering  anticomplementary effects; in 2 other monkeys doubtful fixation was obtained 
with 10 per cent suspensions of the glands.  On the other hand, among 7 unvaccinated con- 
trols, 1 only failed to produce considerable  quantities of antigen.  This exception  (M 27) 
gave evidence of having had a previous encounter with the virus.  If, instead of the number 
of animals, the number of glands with titers of 75 or below are considered, it is found that of 
27 glands from the vaccinated group, 17 contained little or no antigen whereas it v<as lacking 
in only 2 among 14 of the glands derived from the controls.  In Table IV these data are further 
analyzed.  To the results obtained with the unvaccinated monkeys mentioned in Table III, 
are added the titers of the glands from 21 other animals which have been presented in Table I. 3. F.  ENDERS~  L. W.  KANE~  S.  COHEN,  AND  J./-I.  LEVENS  111 
It is evident that whether the analysis is made on the basis of the numbers 
of individuals or of glands, the conclusions which may be drawn are the same. 
Thus approximately 65 per cent of the vaccinated animals yielded glands in 
which little or no antigen could be discerned whereas in about the same pro- 
portion  of unvaccinated monkeys the  titers  of antigen  exceeded 1:150.  In 
about 25  to 30 per cent of both groups a  moderate amount of antigen  (titer 
1 : 150) was demonstrated.  Although the numbers, especially in the vaccinated 
group, are small and although  the mode of preparation of the vaccines and 
their dosage varied as well as the quantity of virus, it would seem reasonable 
to attribute these differences mainly to a prophylactic effect of the vaccination. 
TABLE IV 
Complement-Fixing Antigen in Glands of Normal and Vaccinated Monkeys 
Monkeys with one o~ bo~_~ glands havi  titer o___~f 
Monkeys  <75  75  150"  [  >150 
Per  Per  o  Per  Per 
No.  cent  No.  cent  N  .  cent  No.  cent 
Normal ................  --~  ~  T  ~  ---9--/3-~---[--~8 [  6-~-  -- 
Vaccinated  ............  7  143.8  I  3  I 18.7  /  4  125  [  2  112.5 
Glands having titer of 
Glands from monkeys  .....  <75  75  150:~  >150  TotalNo. 
..  Per  "'o  Per  ..  Per  "'o  Per 
l~o.  cent  ±~  "  cent  ±~o.  cent  ~  "  I  cent  __ 
Normal  ................  2  4.1  I  3  I  6.1  12  24.6[  32  165 
Vaccinated  .............  11  140.8 I  5  [ 18.5 ]  8  [29.6[  3  [ 11.1 
Total 
No. 
29 
16 
49 
27 
* Monkeys yielding glands with titers between 75 and 150 are included. 
~t Glands with fiters between 75 and 150 axe included. 
But it is equally manifest that none of the procedures was universally effec, 
tire.  Apparently the response of the individual animal to the antigen varied 
considerably and it is this variation of the host rather than the differences in 
the quantities of vaccine or its mode of preparation which seems best to account 
for the lack of uniformity in the degree of resistance which is recorded. 
A comparison of the quantity of antigen in the gland and the titer of antibody 
in the serum at the time the virus was inoculated (Table III,  columns 6,  7, 
and 8) fails to reveal a uniform inverse relationship between these two reagents. 
It is, therefore, impossible to affirm that the antibody concerned in complement 
fixation is by itself responsible for protection.  Accordingly we must assume 
that another factor or factors are in part, at least, responsible for the enhanced 
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The  same  comparison,  however,  shows  that  the  antibody  was  present  at 
the time of the challenge inoculation in 8 of the 10 vaccinated animals which 
had little  or no detectable  antigen  in their glands.  In 1 of the  2  exceptions 
(M  25),  antibody had been found 2  days before  and  in  the  other  (M  37)  1 
gland had a  moderate quantity of antigen,  suggesting only a  slight degree of 
resistance.  It would seem, then, that although the antibody cannot be neces- 
sarily correlated with resistance, it was usually present in those animals which 
proved more or less refractory to the inoculation of the virus.  Therefore this 
serum factor cannot be entirely eliminated  as a  participant  in resistance. 
It will be observed from inspection of column 9 of Table III that in nearly 
all  the  vaccinated  monkeys  the  quantities  of  complement-fixing  antibody 
following the challenge inoculation of virus increased  to levels comparable  to 
those of the unvaccinated  animals. 
Two possible explanations for this phenomenon present  themselves.  The inoculation of 
virus may simply act as a third antigenic stimulus which might lead temporarily to the further 
increases in antibody.  That the introduction  of inactivated  virus into the par0tid  gland of 
normal monkeys can give rise to the formation of antibody has been established in experiments 
which are not here recorded in detail  On the other hand,  the increase may be dependent 
upon the establishment  of a mild atypical infection in which multiplication of virus is slight 
but which is sufficient to raise the antibody level to that of the ordinary convalescent.  It 
would be difficult to obtain direct evidence for the validity  of this conception.  If it were 
found that antibody were demonstrable for many months in the serum of such animals, one 
would be inclined to regard its persistence as the result of infection and not that of simple 
antigenic  stimulation.  Since we have  made  no determination  of antibody later  than  3 
months after the inoculation of vaccinated monkeys, such evidence is not available.  It can be 
stated,  nevertheless, that at this time antibody was still present. 
In spite  of the fact  that  only about  two-thirds  of the vaccinated  animals 
gave evidence of resistance  to intraparotid  inoculation  of the virus,  there  is 
reason to believe that the use of vaccine as a  means of prophylaxis in human 
beings might be effective.  Not only have tests in human subjects (16) already 
afforded a certain amount of direct support for this belief, but it must be remem- 
bered that the experimental conditions in the case of the monkeys would seem 
to be  such as  to provide a  much more rigorous trial  of resistance  than  that 
which would occur under natural  conditions of infection.  Thus considerable 
quantities  of virus have been brought directly in contact with the cells of the 
parotid gland in a manner which would seem largely to preclude the participa- 
tion of any protective factors which may exist in the serum of these animals. 
Passive Immunization  with Human Convalescent Mumps Serum and Globulin 
Concentrate.--Johnson  and  Goodpasture  (6)  were unable  to demonstrate  un- 
equivocally any protective or neutralizing properties in the convalescent serum 
of man  or monkey  employing  the  latter  as  the  experimental  animal.  The 
techniques  described  in  this  communication seemed  to  furnish  the means  of 
securing further  evidence in respect  to the problem.  Two experiments  have J. F. ENDERS, L. W. KANE, S. COHEN, AND J. H. LEVENS  113 
been  carried  out.  In  one  pooled  human  convalescent  mumps  serum  was 
employed  and  in  the  other  the  globulin  concentrate  prepared  by E.  J.  Cohn 
and his collaborators from the same pooled convalescent serum  (30).  In both 
experiments  the  serum  or globulin was  mixed with  a  suspension  of virus and 
inoculated into  the parotid  glands of monkeys.  The details of procedure  and 
the results are given in  the following protocols. 
Protocol  1.--The  Effect  of Human  Convalescent  Mumps  Serum 
The pool consisted of sera from 177 individuals convalescent from mumps and collected at 
Camp McCoy by Major Aims C. McGuinness, of the Commission on Measles and Mumps, 
during the winter of 1943.  Its complement-fixing titer was between 1:192 and 1:384.  The 
virus consisted of a  saline suspension  of the parotid gland from the 10th monkey passage. 
Mixtures of equal parts  of virus and  undiluted  serum were prepared  as noted below and 
allowed to stand at about 27°C. for ½ hour.  Each monkey was given 1 ml. of mixture or of 
virus alone into the right parotid.  The left gland was not inoculated.  Before inoculation no 
antibody was found in the monkeys' sera. 
Both glands were removed from each animal 6 days later when definite enlargement of the 
right gland was noted in all except M  21.  In each the amount of antigen was determined. 
None was demonstrated  in the glands which had not been inoculated.  The results of the 
titrations of the inoculated glands were as follows:-- 
"liter of antigen 
in right parotid 
Monkey No.  Inoculum  gland 
18  Virus diluted 1:80 and serum  52 
19  "  "  1:40  "  "  150 
20  "  "  1 : 20  "  "  75 
21  "  "  1:40.  No serum  1200 
22  "  "  1:160  "  "  600 
Clearly  the  quantity  of  antigen  in  the  glands  of  the  monkeys  which  had 
received mixtures  of serum  and virus was less than  that found in both  Of the 
animals  which  received virus  only.  In  none  of  the  3  monkeys,  however,  in 
which  the serum  appears  to have exerted an inhibitory  effect on  the increase 
of the antigen  was  its formation  entirely suppressed. 
It is obvious, of course, that to determine by means of the technique we have employed 
whether or not such serum possesses  true virus-neutralizing properties, it would be essential 
to ascertain the minimal infecting dose of virus.  Since we are ignorant of it, the doses of 
virus which we have used in this and  the following experiment may possibly exceed any 
neutralizing capacity of the serum. 
Protocol 2.--The  Effect  of the Globulin  Concentrale 
The globulin concentrate was  prepared  from the pool already mentioned.  Its  titer  of 
antibody was between 1:1800 and  1:3600.  A mixture of equal parts of concentrate and a 
1:20 suspension of a  gland of the llth monkey passage was prepared,  allowed to stand at 
room temperature (i.e. about 21°C.)  for 1 hour.  One ml. of the mixture was inoculated into 
each duct of 2 monkeys.  As controls 2 other monkeys were also inoculated with virus only. 114  n~MUNXTY IN ~J~ms.  i 
Antibody was not demonstrated in the serum of any of the monkeys before inoculation.  On 
the 6th day swelling of both glands of the controls was apparent.  No definite glandular en- 
largement was observed in the animals which received the mixtures.  The glands of all the 
monkeys were removed and, with one exception, their content of antigen determined.  The 
results were as follows:-- 
Monkey No. 
62 
20-58 
20-49 
20-56 
* Right parotid. 
Inoculum  Titer of antigen in gland 
RP*  LP$ 
Virus diluted 1 : 20 and globulin  < 75  < 75 
"  "  "  "  "  75  75 
"  "  1: 40  105  130 
~C  ~t  c~  600  -- 
Left parotid. 
As with the convalescent serum, there would appear to be a definite inhibition 
by the concentrate upon the increase of the antigen, but again complete sup- 
pression of viral activity was not obtained in the case of M  20-58, although in 
M  62 no antigen could be shown. 
These findings strongly imply that it is not, as suggested above, the lack of 
sufficient antibody to neutralize the virus which is responsible for the failure 
to obtain complete suppression of viral multiplication as reflected by the in- 
crease of antigen; more probably either an efficient neutralizing factor is absent 
or the conditions of the experiment are such as to preclude in most instances 
its effective operation. 
The final solution of this problem would seem to depend on the results of 
controlled tests in human beings in whom mumps can be produced by spraying 
the virus into the oral cavity, since it is not unlikely that circulating antibody 
may be much  more effective in interfering with the pathogenesis of the natural 
disease than in that of the infection induced by direct inoculation of the sus- 
ceptible tissue. 
S~ARY 
Since the experimental  data have already been discussed at some length, 
it is here necessary only to review those observations which appear to be of 
most significance. 
The manifestations of the disease we have produced in monkeys have in 
general been similar to those described by previous workers.  It has been 
found that members  of the species M. mulatta  are regularly susceptible to 
infection  with the  virus  of  mumps, provided they have not been in contact with 
animals which have recently  been infected.  Such contact may be followed by 
the development  of resistance to inoculation unattended  by overt signs of 
infection. 
Following  the intraparotid injection of virus into a susceptible animal, an 
antigen  appears  in  the  gland  which  reacts  specifically in  the  complement 
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mumps.  This antigen has not been demonstrated in any other organ of the 
infected monkey which has been examined, nor does it persist or increase in 
amount when introduced into the brain or the testes.  Attempts to propagate 
it in the tissues of other animal species including the developing hen's egg and 
tissue cultures have so far been uniformly unsuccessful.  The antigen is rela- 
tively thermostabile, resisting a  temperature of 65°C.  for at least 20 minutes 
at the optimal hydrogen ion concentration.  It is unimpaired by a  concentra- 
tion of formalin of 0.3 per cent.  Together with the virus it may be preserved 
indefinitely in the frozen state.  The maximal quantity of antigen in the gland, 
which  may be  considerable,  is  attained  on  or  about  the  5th  day following 
inoculation of the virus. 
An antibody which reacts with the antigen appears in the serum from 8 to 
14 days after infection.  This antibody has not been found in the serum of 
normal monkeys which have had no opportunity for contact with  the virus. 
It has  been demonstrated during  convalescence in  the  serum  of all animals 
which have been examined.  The antibody which is present in large amounts 
soon  after recovery, although  decreasing in  concentration with  the lapse of 
time, may continue to be present for many months.  At 62°C. for 20 minutes 
its activity is not reduced and on storage at 4°C. its titer has remained unaltered 
for over 2 years.  A similar factor which appears in human beings convalescent 
from mumps is less stabile, since its activity is reduced appreciably under these 
conditions.  In the  COs  cabinet, however, both antibodies can be preserved 
for long periods of time. 
The definition of these  reagents  has  afforded means  whereby the  simian 
infection with the virus of mumps,  whether it is actively in progress or has 
occurred at some time in the past, can be recognized. 
Upon the  establishment  of these facts,  the estimation  of the  quantity  of 
antigen in the glands of vaccinated animals  was employed as an index of their 
resistance in  studies  on  the  effect of  the  injection of formolized and alum- 
precipitated  formolized suspensions  of infected parotid  gland.  It  has  been 
shown that such vaccines, in which the virus has been rendered inactive, lead 
to the production of complement-fixing antibody.  In about 60 per cent of the 
vaccinated animals, moreover, evidence of increased resistance was obtained as 
indicated by the partial or complete suppression of the formation of antigen in 
the  inoculated  gland.  In  certain  instances  no  evidence  of  resistance  was 
observed, yet antibody was found to be present.  It is clear, therefore, that 
resistance is not determined solely by the presence of the complement-fixing 
antibody.  The possibility, however, of its participation as a factor in immunity 
cannot be excluded. 
Employing the same criterion of resistance,  the virus-neutralizing capacity 
of a  pool of human mumps convalescent sera and of a  globulin concentrate 
prepared from the pool has been studied.  Neither of these materials was found 116  IMMUNITY IN MUMPS.  I 
to prevent entirely the formation of antigen, although each of them appeared 
to exert some inhibitory effect. 
We are grateful to Brigadier General  F. F. Russell for pointing out to us the desirability of 
further studies on the virus of mumps.  To Dr. Conrad Wesselhoeft  we are indebted for his 
valuable help in furnishing  clinical  material from patients and for constant encouragement  and 
advice.  Thanks are due to Dr. J. L. Oncley for carrying out the ultracentrifugation of the 
antigen, and to Miss Beatrice Payson for essential technical assistance. 
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